"An appealing feature of [intermittent fasting] is that dieters do not have to focus on counting calories and restricting ...

A team of pharmaceutical researchers at Novartis Biomedical Research, working with an international team of associates, has ...

The solution is especially beneficial for organisations looking to “consolidate” sourcing efforts and minimise trial delay ...

There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian ...

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...